<DOC>
	<DOCNO>NCT00741286</DOCNO>
	<brief_summary>RATIONALE : - Elevation pulsatility index ( PIs ) , measure transcranial Doppler ( TCD ) , postulate reflect downstream increase vascular resistance cause small-vessel disease ( SVD ) . - Small arterial vessel significant determinant vascular resistance PIs elevate SVD present intracranial circulation . - Cilostazol , phosphodiesterase III inhibitor , non-antiplatelet effect , vasodilation neuroprotective effect . It show effective secondary prevention stroke especially SVD may relate non-antiplatelet effect cilostazol . OBJECTIVES : - In study , aim investigate whether cilostazol affect change PIs patient acute lacunar infarction use serial TCDs . - Our hypothesis cilostazol non-antiplatelet effect vasodilation effect may decrease vascular resistance patient acute lacunar infarction . Hence , cilostazol decrease PIs patient acute lacunar infarction .</brief_summary>
	<brief_title>Effect Cilostazol Acute Lacunar Infarction Based Pulsatility Index Transcranial Doppler</brief_title>
	<detailed_description>TREATMENTS : - Cilostazol agent inhibit platelet aggregation . - A matching placebo cilostazol inactive substance look similar active cilostazol tablet . TREATMENT PLAN : - There two treatment group ; one receive cilostazol 200mg ( 100mg twice per day ) , second match placebo cilostazol . - These study drug administer top aspirin ( 100mg ) systematically prescribed patient PRIMARY ENDPOINT : - The change PI baseline 14 90 day follow-up study . STUDY EXECUTION : - Two hundred sixty patient , present first ever lacunar infarction within 7 day onset symptom recruit within two year . - Patients follow three month .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Stroke , Lacunar</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Patients first ever lacunar infarction within 7 day onset symptoms Age : 45 year age Patients contraindication treatment antiplatelet therapy Patients potential cardiac embolic source ; prosthetic valve , atrial fibrillation , atrial flutter , leave atrial/atrial appendage thrombus , sick sinus syndrome , leave ventricular thrombus , dilate cardiomyopathy , akinetic hypokinetic leave ventricular segment , atrial myxoma , Infective endocarditis , mitral valve stenosis prolapse , mitral annuls calcification , leave atrial turbulence , nonbacterial endocarditis , congestive heart failure , recent myocardial infarction ( within 4 week ) Bleeding diathesis Chronic liver disease ( ALT &gt; 100 AST &gt; 100 ) chronic renal disease ( creatinine &gt; 3.0mg/dl ) Anemia ( hemoglobin &lt; 10mg/dl ) thrombocytopenia ( platelet count le 100,000/mm3 ) Nonatherosclerotic vasculopathy ; patient clinical characteristic suggest arterial dissection , moyamoya disease , Takayasu 's arteritis , radiation associate angiopathy , vasculitis . Pregnant lactating patient Patients hyperthyroidism COPD Patients current anticoagulation antiplatelet therapy Patients poor temporal window transcranial Doppler</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Cerebral infarction</keyword>
	<keyword>Cilostazol</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Transcranial Doppler</keyword>
	<keyword>Pulsatile Index</keyword>
</DOC>